Reactive and Inactive Skin Decontamination Lotion
ID: SPE2DP21R0132Type: Justification
AwardedDec 27, 2022
Award #:SPE2DP23D0001
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/da5270697d5e4fb4a329182af5325091/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking procurement for Reactive and Inactive Skin Decontamination Lotion (RSDL/ISDL). This contract involves the acquisition of specialized drugs and biologicals designed for decontaminating skin exposed to hazardous substances, which is critical for the safety and protection of military personnel in various operational environments. The opportunity is detailed in a redacted Justification and Approval document, indicating the importance of these products in maintaining troop readiness and safety. Interested vendors can reach out to Myrna I. Rodriguez at Myrna.Rodriguez@dla.mil or call 215.737.4711 for further information regarding this procurement.

    Point(s) of Contact
    Myrna I. Rodriguez
    (215) 737-4711
    Myrna.Rodriguez@dla.mil
    Similar Opportunities
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Metaxalone Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for Metaxalone Tablets, specifically 800 MG tablets available in 100-count and 500-count bottles. This procurement aims to secure a reliable supply of this pharmaceutical product, which is essential for various medical applications within military healthcare. Interested vendors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) between November 7 and December 7, 2025, by 3:00 PM EST, and are required to adhere to specific contract terms, including a subcontracting plan for large businesses and compliance with various federal regulations. For further inquiries, potential offerors can contact Jeremy Brown at jeremy.brown@dla.mil or Jason Wray at Jason.wray@dla.mil.
    RapidRx IntelliCab 4 Drawer Cabinet
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking procurement for the RapidRx IntelliCab 4 Drawer Cabinet, a medical and surgical instrument essential for healthcare operations. This cabinet is designed to enhance the efficiency of medication management and distribution within military medical facilities. The procurement emphasizes the importance of reliable and advanced medical equipment in supporting troop health and operational readiness. Interested vendors can reach out to John Jackson at 301-619-4485 or via email at john.r.jackson@dla.mil, or contact Lucas Denault at 301-619-9888 for further inquiries regarding this opportunity.
    Ondansetron Orally Disintegrating Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 MG and 8 MG tablets in various count bottles. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for treating nausea and vomiting in patients, and will be available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in September 2025, although the DLA reserves the right to issue it earlier or later. Interested parties should direct inquiries to Nancy Fernandez at nancy.fernandez@dla.mil or call 445-737-0713, and are encouraged to set up automated notifications for any changes to the solicitation through the DLA Bid Board System and Sam.Gov.
    R Series Advanced Life Support Monitor/Defibrillator
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking procurement for the R Series Advanced Life Support Monitor/Defibrillator. This equipment is critical for medical and surgical applications, specifically categorized under the PSC code 6515, which encompasses medical instruments, equipment, and supplies. The monitor/defibrillator plays a vital role in emergency medical situations, providing essential life support capabilities. Interested vendors can reach out to Anthony Giunta at Anthony.Giunta@dla.mil or by phone at 215-737-2126 for further details regarding this opportunity.
    Trazodone - Solicitation
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for Trazodone tablets in various dosages and bottle counts. This procurement aims to secure a substantial quantity of pharmaceutical supplies essential for military and healthcare operations. Offerors are required to submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries regarding the solicitation.
    MOLLE 4000 RUCKSACK SET
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking to procure the MOLLE 4000 Rucksack Set, as authorized by the solicitation SPE1C1-23-R-0015. This procurement aims to fulfill the need for individual equipment essential for military operations, with the potential for one additional contract award under the same solicitation in the future. The awarded contracts include SPE1C1-23-C-0006, SPE1C1-23-C-0007, SPE1C1-23-C-0008, and SPE1C1-23-C-0009, highlighting the importance of this equipment in supporting troop logistics. For further inquiries, interested parties can contact Catherine Dillon at 215-737-2497 or via email at Catherine.Dillon@dla.mil.
    Rabeprazole Sodium Delayed Release Tablets
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.
    65 -- Hospital Supply Division
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking procurement for hospital supplies under the title "65 -- Hospital Supply Division." This opportunity involves the acquisition of hospital furniture, equipment, utensils, and supplies, which are critical for maintaining healthcare standards within military facilities. The goods procured will support the operational readiness and medical capabilities of the armed forces. Interested vendors can reach out to James Smith at james.smith@dla.mil or 215-737-0360, or Evan Lessin at evan.lessin@dla.mil or 215-737-0749 for further details regarding this procurement opportunity.
    RFI for Joint Project Manager for Chemical, Biological, Radiological and Nuclear Protection (JPM CBRN P) Hazard Mitigation
    Dept Of Defense
    The Department of Defense, specifically the Joint Project Manager for Chemical, Biological, Radiological and Nuclear Protection (JPM CBRN P), is conducting a Request for Information (RFI) to identify decontaminant technologies capable of mitigating hazardous contamination. The objective is to gather information on tactical and operational decontaminants that can effectively reduce health risks from chemical and biological agents, allowing warfighters to maintain operational readiness. This initiative is crucial for ensuring the safety and effectiveness of military personnel in contaminated environments. Interested vendors are invited to submit a summary of their technologies by January 23, 2026, to Lorraine Cline at lorraine.m.cline.civ@army.mil or Veronica St. Claire at veronica.a.stclaire.civ@army.mil, with detailed specifications and efficacy data included in their responses.